{"id":466306,"title":"Exemple 1 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"fr","captureDate":"2026-01-05","captureTimestamp":"2026-01-05T07:59:26.352000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/prolongation-intervalle/ebauche-ligne-directrice-intention-industrie-allongement-intervalle-contenu-monographies-produit-exemple-1.html","snippet":"Exemple 1 Exemple 1 : Tableau de l'augmentation moyenne maximale de l'intervalle QTc Traitement /Dose Multiple de la dose maximale recommandée N Moment de l'augmentation moyenne maximale du QTc (correction par rapport aux valeurs de base et au placebo) Augmentation moyenne…","rawSnapshotUrl":"/api/snapshots/raw/466306","browseUrl":"https://replay.healtharchive.ca/job-6/20260105075926/https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/prolongation-intervalle/ebauche-ligne-directrice-intention-industrie-allongement-intervalle-contenu-monographies-produit-exemple-1.html#ha_snapshot=466306","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}